Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Research & Development (2009 - 2026)

Updated

Immucell's Research & Development was $176,771 in Q3 2026, down 74.5% from $694,311 a year earlier but up 47.7% from the prior quarter.

Analysis

Immucell (ICCC) Research & Development (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immucell's Research & Development was $1.37 million through Sep 30, 2026, down 55.7% year-over-year; for FY2025, it was $3.04 million, down 22.0% from FY2024.

  • Research & Development has now declined for three consecutive years, with a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
  • In earlier years, Research & Development was $3.9 million in FY2024 (-11.3%), $4.39 million in FY2023 (-2.2%), $4.49 million in FY2022 (+7.8%) and $4.17 million in FY2021 (-4.3%).
  • Quarterly Research & Development has moved between $119,652 (Q2 2026) and $1.27 million (Q3 2022) over five years.
  • Compared with a year earlier, Research & Development has declined for seven straight quarters, with an average decline of 42.4% over the last seven quarters.
  • The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 21.2%); the worst was Q2 2026 (a decline of 85.6%).
  • Per Business Quant data, ICCC's Research & Development in the three quarters before Q3 2026 was $119,652 (Q2 2026), $317,688 (Q1 2026) and $758,864 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 176,771.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 176,771.00
Jun 30, 2026 119,652.00
Mar 31, 2026 317,688.00
Dec 31, 2025 758,864.00
Sep 30, 2025 694,311.00
Jun 30, 2025 831,858.00
Mar 31, 2025 756,847.00
Dec 31, 2024 819,393.00
Sep 30, 2024 786,136.00
Jun 30, 2024 1.03 Mn
Mar 31, 2024 1.26 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 1.27 Mn
Jun 30, 2022 1.14 Mn
Mar 31, 2022 1.04 Mn
Dec 31, 2021 1.09 Mn
Sep 30, 2021 1.05 Mn
API Access

Immucell Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ICCC&period=max&api_key=YOUR_API_KEY